menu
    • menu

    Company profile for Mapi Pharma

    NEW Drugs in Dev: 2
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    SERVICES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a late clinical stage pharmaceutical company, engaged in the development of improved extended-release versions of existing commercially successful products, which we refer to as life cycle management, or LCM products, that target large markets, as well as high-barrier to entry and high-added value generic drugs. Our core capabilities are in long acting depot injectable drugs that are complex formulations in sterile prod...
    We are a late clinical stage pharmaceutical company, engaged in the development of improved extended-release versions of existing commercially successful products, which we refer to as life cycle management, or LCM products, that target large markets, as well as high-barrier to entry and high-added value generic drugs. Our core capabilities are in long acting depot injectable drugs that are complex formulations in sterile production. We are fully integrated in our activities and are built on strong chemical and pharmaceutical R&D capabilities, a deep understanding of the global market and of regulatory needs. Mapi is headquartered in Israel.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Mapi PharmaIsrael Flag
    Country
    Country
    Israel
    Address
    Address
    Weizmann Science Park 16 Einstein St. P.O. Box 4113 Ness Ziona, Israel 74140
    Telephone
    Telephone
    +972-73-7121213
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://mapi-pharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BePharma

    Not Confirmed

    envelop Contact Supplier

    BePharma

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Mapi Pharma Hosts Virtual KOL Event On Glatiramer Acetate
    Mapi Pharma Hosts Virtual KOL Event On Glatiramer Acetate

    19 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/19/3241200/0/en/Mapi-Pharma-to-Host-Virtual-KOL-Event-to-Discuss-Glatiramer-Acetate-Once-a-Month-Depot-for-Primary-Progressive-Multiple-Sclerosis-on-March-3-2026.html

    GLOBENEWSWIRE
    19 Feb 2026
    Share Share
    Mapi to Present Ph II Data of Long-Acting GA in PPMS at ACTRIMS
    Mapi to Present Ph II Data of Long-Acting GA in PPMS at ACTRIMS

    03 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/03/3231266/0/en/Mapi-Pharma-to-Present-New-Safety-and-Efficacy-Data-from-Glatiramer-Acetate-Depot-Long-Acting-Injection-Phase-II-Study-in-Patients-with-Primary-Progressive-Multiple-Sclerosis-PPMS-.html

    GLOBENEWSWIRE
    03 Feb 2026
    Share Share
    Mapi Pharma Seeks Partners For Long-Acting Peptide Depot
    Mapi Pharma Seeks Partners For Long-Acting Peptide Depot

    01 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/01/3197080/0/en/Mapi-Pharma-is-Seeking-New-Partnerships-for-Long-Acting-Depot-Drugs-of-Peptides-for-Self-Administration.html

    GLOBENEWSWIRE
    01 Dec 2025
    Share Share
    Mapi Pharma Initiates Phase-I/II Trial for Monthly Cariprazine
    Mapi Pharma Initiates Phase-I/II Trial for Monthly Cariprazine

    17 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/17/3151767/0/en/Mapi-Pharma-Announces-First-Patient-Recruited-in-Phase-I-II-Study-of-Cariprazine-Depot-Once-Monthly-Injection.html

    GLOBENEWSWIRE
    17 Sep 2025
    Share Share
    FDA Rejects Viatris, Mapi’s Long-Acting Multiple Sclerosis Injection
    FDA Rejects Viatris, Mapi’s Long-Acting Multiple Sclerosis Injection

    12 Mar 2024

    // BIOSPACE

    https://www.biospace.com/article/fda-rejects-viatris-mapi-s-long-acting-multiple-sclerosis-injection/

    BIOSPACE
    12 Mar 2024
    Share Share
    Viatris and Mapi Pharma Announce FDA Acceptance of NDA Filing for GA Depot
    Viatris and Mapi Pharma Announce FDA Acceptance of NDA Filing for GA Depot

    07 Aug 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/viatris-and-mapi-pharma-announce-fda-acceptance-of-new-drug-application-filing-for-ga-depot-for-the-treatment-of-relapsing-forms-of-multiple-sclerosis-301894145.html

    PR NEWSWIRE
    07 Aug 2023
    Share Share

    Services

    Upload your portfolio for free, ask us

    API & Drug Product Development

    Click here to discover the service providers for API & Drug Product Development

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search